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Optimal  follow-up  in  adult  patients  with  congenital
heart  disease  and  chronic  pulmonary  regurgitation:
Towards  tailored  use  of  cardiac  magnetic  resonance
imaging
Suivi  optimal  des  patients  adultes  ayant  une  cardiopathie  congénitale  et  une
insufﬁsance  pulmonaire  chronique  :  vers  une  utilisation  adaptée  de  l’imagerie
cardiaque  par  résonance  magnétique
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Summary
Background.  —  Pulmonary  regurgitation  (PR)  is  a  common  complication  of  right  ventricular  out-
ﬂow tract  (RVOT)  reconstruction  and  leads  to  right  ventricular  (RV)  dilatation  and  dysfunction.
Abbreviations: CI, conﬁdence interval; CMR, cardiac magnetic resonance; ECG, electrocardiography/graphic; EDRV, end-diastolic right
ventricular; EF, ejection fraction; ESRV, end-systolic right ventricular; IVA, isovolumic acceleration; LV, left ventricular; OR, odds ratio; PHT,
pressure half time; PR, pulmonary regurgitation; PVR, pulmonary valve replacement; RV, right ventricular; RVEF, right ventricular ejection
fraction; RVOT, right ventricular outﬂow tract; TDI, tissue Doppler imaging; ToF, tetralogy of Fallot; TR, tricuspid regurgitation; VENC,
velocity encoding.
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Although  cardiac  magnetic  resonance  (CMR)  is  the  gold  standard  for  evaluating  PR  and  RV
dysfunction,  cost  and  limited  availability  are  problems  in  many  centres.
Aims.  —  To  determine  clinical,  electrocardiographic  and  echocardiographic  predictors  of  these
complications  and  optimize  patient  selection  for  their  short-term  follow-up  by  CMR.
Methods.  —  Ninety-four  patients  with  a  history  of  RVOT  repair  were  prospectively  included.  All
patients had  a  clinical  examination,  electrocardiography,  echocardiography  and  CMR.
Results. —  QRS  duration,  indexed  end-diastolic  RV  (EDRV)  diameter  and  area  on  echocardiogra-
phy were  signiﬁcantly  associated  with  RV  dilatation  on  CMR  (P  <  0.001).  The  distal  localization
of Doppler  PR  ﬂow  was  the  strongest  echocardiographic  criterion  associated  with  severe  PR
(P <  0.001).  Arrhythmia  history  and  high  Tei  index  were  signiﬁcantly  associated  with  low  RV
ejection fraction  (P  <  0.001  and  P  =  0.017,  respectively).  In  multivariable  analysis,  grade  of  PR,
QRS duration,  arrhythmia  and  valvulotomy  were  strongly  associated  with  severe  PR  and  RV
dilatation  or  systolic  RV  dysfunction.  From  these  results,  an  approach  based  on  a  scaled  sco-
ring system  for  selecting  patients  who  need  short-term  CMR  evaluation  and  close  follow-up  was
evaluated.  This  method  should  avoid  31%  of  CMR  examinations,  with  a  sensitivity  of  97.7%.
Conclusion.  —  Clinical,  electrocardiographic  and  echocardiographic  criteria  can  be  used  to
accurately  evaluate  patients  with  RVOT  repair.  The  combination  of  such  features  facilitates
identiﬁcation  of  patients  who  do  or  do  not  require  close  CMR  evaluation.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  L’insufﬁsance  pulmonaire  (IP)  est  une  complication  fréquente  de  la  reconstruction
de la  voie  droite  et  entraîne  une  dilatation  et  une  dysfonction  du  ventricule  droit  (VD).  Bien
que l’imagerie  par  résonance  cardiaque  soit  la  référence  pour  évaluer  l’IP  et  la  fonction  VD,
son coût  et  sa  disponibilité  limitée  sont  problématiques  dans  de  nombreux  centres.
Objectifs.  — Déterminer  les  critères  cliniques,  ECG  et  échocardiographiques  prédictifs  de  ces
complications  et  optimiser  la  sélection  des  patients  pour  un  suivi  à  court  terme  de  ces
complications  par  IRM.
Méthodes.  — Quatre-vingt-quatorze  patients  ayant  des  antécédents  de  reconstruction  de  la  voie
droite ont  été  inclus  prospectivement.  Tous  les  patients  avaient  un  examen  clinique,  un  ECG,
une échocardiographie  et  une  IRM.
Résultats.  — La  durée  du  QRS,  le  diamètre  et  la  surface  télédiastoliques  indexés  du  VD  en
échocardiographie  étaient  signiﬁcativement  associés  à  une  dilatation  VD  en  IRM  (p  <  0,001).  La
localisation  distale  de  l’IP  au  Doppler  était  le  critère  le  plus  fortement  corrélé  à  une  IP  sévère
diagnostiquée  en  IRM  (p  <  0,001).  Les  antécédents  d’arythmies  et  un  indice  de  Tei  augmenté
étaient signiﬁcativement  associés  à  une  dysfonction  VD  (p  <  0,001  et  p  =  0,017,  respectivement).
En analyse  multivariée,  le  grade  de  l’IP,  la  durée  du  QRS,  l’arythmie  et  une  valvulotomie  étaient
fortement associés  à  une  IP  sévère  et  une  dilatation  VD  importante  ou  à  une  dysfonction  sys-
tolique VD.  À  partir  de  ces  résultats,  une  approche,  basée  sur  un  système  de  scores,  pour
sélectionner  les  patients  qui  ont  besoin  à  court  terme  d’une  évaluation  IRM  a  été  évaluée.
Cette méthode  permettrait  d’éviter  31  %  des  examens  IRM,  avec  une  sensibilité  de  97,7  %.
Conclusion.  —  Des  critères  clinique,  ECG  et  échocardiographiques  peuvent  être  utilisés  pour
évaluer avec  précision  les  patients  ayant  une  chirurgie  de  la  voie  droite.  La  combinaison  de
ces caractéristiques  permet  de  déterminer  les  patients  qui  nécessitent  ou  pas  une  évaluation
rapprochée  en  IRM.
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ulmonary  regurgitation  (PR)  is  a  common  complication  of
ight  ventricular  outﬂow  tract  (RVOT)  reconstruction  and
ubsequent  remodelling.  Untreated  severe  PR  may  lead  to
rreversible  right  ventricular  (RV)  dilation  and  dysfunction.
hen  timely  pulmonary  valve  replacement  (PVR)  is  per-
ormed,  there  is  most  often  a  reduction  in  RV  size  and  an
mprovement  in  RV  ejection  fraction  (RVEF).  In  contrast,
hen  PVR  is  performed  late,  RV  recovery  is  incomplete  [1].
herefore,  reasonably  accurate  quantiﬁcation  of  the  degree
r
a
as  droits  réservés.
f  PR  and  RV  size  and  function  is  important  in  the  manage-
ent  and  follow-up  of  these  patients.
Cardiac  magnetic  resonance  (CMR),  an  accurate  non-
nvasive  imaging  modality,  has  become  the  gold  standard  for
he  evaluation  of  patients  with  RVOT  reconstruction  and  is
ow  required  for  screening  patients  who  require  PVR  [2—4].
owever  CMR  is  time  consuming  and  can  be  costly  in  a  strat-
gy  requiring  close  CMR  follow-up  in  all  patients  after  RVOT
econstruction.  Echocardiography  is  more  widely  available
nd  allows  an  assessment  of  PR  and  RV  size  and  function,
lthough  the  limitations  of  ultrasound-based  methods  are
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well  known.  Few  studies  have  compared  echocardiography
with  CMR  for  the  evaluation  of  RV  volumes  and  function
[5—9]  or  the  degree  of  PR  [10—13]  in  the  tetralogy  of  Fal-
lot  (ToF)  population.  Most  often,  quantitative  criteria  are
tested  separately.
According  to  the  recent  European  Society  of  Cardiology
recommendations  [2],  all  patients  with  RVOT  reconstruc-
tion  should  have  an  annual  cardiac  follow-up  to  look  for
complications,  and  echocardiography  should  be  performed
as  part  of  each  visit.  All  patients  should  have  further  CMR
during  the  ﬁrst  visit  to  a  specialized  Grown  Up  Congeni-
tal  Heart  centre.  But  the  necessity  and  intervals  for  repeat
CMR  are  not  precisely  discussed  when  no  complication  is
found  by  clinical  and  echocardiography  evaluation.  There
are  no  studies  deﬁning  subgroups  of  patients  at  high  risk  of
complications,  who  justifying  close  CMR  follow-up.
Thus,  we  aimed  to  test  the  clinical,  electrocardiographic
(ECG)  and  echocardiographic  criteria  and  to  combine  varia-
bles  readily  available  in  a  simple  score  that  would  better
deﬁne  patients  with  a  high  risk  of  complications,  to  deﬁne
a  tailored  screening  strategy  and  determine  the  optimal  use
of  CMR  in  the  follow-up  after  RVOT  reconstruction.
Methods
Study population
We  prospectively  included  94  patients  (48  women  and  46
men)  from  January  2008  to  December  2010,  following  ethics
approval  and  informed  consent.  The  main  inclusion  cri-
terion  was  a  history  of  surgical  reconstruction  of  RVOT
(Table  1).  However,  patients  who  underwent  pulmonary
valve  implantation  were  excluded,  as  were  patients  with  a
pacemaker  or  deﬁbrillator.  All  patients  had  a  clinical  exam-
ination,  electrocardiography  (ECG),  echocardiography  and
CMR.  Echocardiography  and  CMR  were  performed  blind  on
Table  1 Patient  and  surgical  characteristics  (n  =  94).
Characteristics
Men 46  (48.9)
Age  at  inclusion  (years)  25  (21—34)
Heart  disease
Tetralogy  of  Fallot  65  (69.1)
Pulmonary  stenosis  12  (12.8)
Double  outlet  right  ventricle 5  (5.4)
Absent  pulmonary  valve  +  VSD 4 (4.2)
Pulmonary  atresia 4 (4.2)
Pulmonary  atresia  +  VSD  3  (3.2)
Truncus  1  (1.1)
Age  of  RVOT  repair  (years)  2  (1—6)
Time  since  surgery  (years)  23  (19—29)
Transannular  patch  61  (64.8)
Valvulotomy  27  (28.7)
Unvalved  conduit  5  (5.3)
Data are number (%) or median (interquartile range). RVOT:
right ventricular outﬂow tract; VSD: ventricular septal defect.
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he  same  day  by  two  different  operators  (M.L.  and  E.M.)
ithin  a  6-hour  period.
chocardiographic measurements
chocardiographic  examinations  were  performed  in  all
atients  with  a  Vivid  7  device  (GE  Medical  Systems,  Horten,
orway)  (Fig.  1).  All  studies  were  stored  digitally  and  were
vailable  for  ofﬂine  analysis  with  Echopac  software  (GE
ealthcare,  Waukesha,  WI,  USA).  RV  diameters  were  mea-
ured  from  the  parasternal  long-axis  view.  End-diastolic  RV
EDRV)  and  end-systolic  RV  (ESRV)  areas  were  measured  from
he  apical  four-chamber  view.  RV  diameters  and  areas  were
ndexed  to  body  surface  area.  The  RV  shortening  fraction
as  calculated  by  the  following  formula:  (EDRV  area  − ESRV
rea)/EDRV  area.  PR  was  assessed  by  pressure  half  time
PHT)  and  regurgitation  index  was  calculated  by  the  ratio
f  PR  duration  over  diastole  duration,  measured  from  the
ulmonary  outﬂow  by  Doppler  in  the  parasternal  short-axis
iew,  with  continuous-wave  sampling  through  the  pulmonary
nnulus.  The  pulmonary  diastolic  retrograde  ﬂow  was  also
etected  between  the  pulmonary  annulus  and  distal  pul-
onary  arteries  with  the  pulsed-wave  sample  volume,  in
he  parasternal  short-axis  view.  PR  was  classiﬁed  as  grade
 (minimal)  in  the  presence  of  a  retrograde  ﬂow  from  the
ulmonary  annulus,  grade  2  (moderate)  in  the  presence
f  a  retrograde  ﬂow  from  the  pulmonary  artery  trunk  and
rade  3  (severe)  if  the  retrograde  ﬂow  was  detected  from
istal  pulmonary  arteries.  Localization  of  diastolic  retro-
rade  ﬂow  for  PR  quantiﬁcation  echocardiography  has  been
lready  validated  with  CMR  measurements  [10,12].  PR  veloc-
ty  was  0—2.5  m/s.  Colour-coded  myocardial  velocities  of
he  tricuspid  annulus  were  acquired  with  a mean  frame
ate  of  147  ±  21  frames/s.  Isovolumic  acceleration  (IVA),
 relatively  load-independent  variable,  was  measured  at
he  lateral  tricuspid  annulus,  as  described  by  Vogel  et  al.
14]. The  peak  of  the  systolic  wave  (S  wave),  which  has
een  demonstrated  to  correlate  with  ejection  fraction  (EF)
15],  was  measured  with  tissue  Doppler  imaging  (TDI)  from
he  lateral  tricuspid  annulus.  The  Tei  index  was  calculated
s  previously  described  [5,8,9],  with  tissue  Doppler  recor-
ings  from  the  lateral  tricuspid  annulus.  Three  consecutive
ardiac  cycles  were  averaged  to  correct  for  heart  rate
ariation  and  measurement  errors  for  all  quantitative  varia-
les.  Tricuspid  regurgitation  (TR)  was  diagnosed  with  colour
ow  imaging.  When  more  than  a  small  central  TR  jet  was
bserved,  the  severity  of  TR  was  graduated  according  Euro-
ean  recommendations  [16], using  vena  contracta  width,
he  ﬂow  convergence  method  and  pulsed  Doppler  evaluation
f  hepatic  vein  ﬂow.  Most  patients  had  mild  TR  (87/94),  six
ad  moderate  TR  and  one  had  severe  TR.
MR measurements
MR  studies  were  performed  on  a  1.5-T  system  (Signa  Hdx;
E  Healthcare,  Milwaukee,  WI,  USA).  Using  retrospective
CG-gated  steady-state  free-precession  cine  images,  left
entricular  (LV)  and  RV  function  were  assessed  by  using
uccessive  breath-hold  acquisitions  in  the  axial  view  from
he  apex  of  the  heart  to  the  aortic  arch,  in  six  to  nine
wo-chamber  views  to  cover  both  ventricles  and  in  a  short-
xis  contiguous  stack  from  the  atrioventricular  ring  to  the
30  M.  Ladouceur  et  al.
Figure 1. Echocardiographic measurements in a patient with tetralogy of Fallot repair. A and B. Moderate right ventricular (RV) dilatation:
RV areas were measured, including trabeculation in cavity area; indexed end-diastolic RV (EDRV) area was 23.3 cm/m2; indexed end-systolic
RV (ESRV) area was 11.5 cm2/m2. Cardiac magnetic resonance (CMR) conﬁrmed these results: EDRV volume was 114 mL/m2; ESRV volume
was 72 mL/m2. C. Severe pulmonary regurgitation (PR) (grade 3) with pulmonary diastolic retrograde ﬂow detected from the left pulmonary
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mrtery; CMR PR fraction was 52%. D. Tei index calculated from tissue
2%.
pex.  Two  to  three  slice  levels  were  acquired  during  a  single
reath  hold.  The  cine  sequence  variables  were:  repetition
ime  2.8  ms;  echo  time  1.4  ms;  ﬂip  angle  45◦;  slice  thick-
ess  8  mm;  matrix  320  × 192;  ﬁeld  of  view  380—300  mm;  and
emporal  resolution  20  ms,  by  using  25—60  cardiac  phases
hroughout  the  cardiac  cycle.  Assessment  of  RV  volumes  was
erformed  by  manually  deﬁning  the  endocardial  outline  at
nd-diastole  and  end-systole  in  each  short-axis  slice,  using
Mass  Analysis  software  (MEDIS  Medical  Imaging  Systems,
eiden,  The  Netherlands).  RV  trabeculae  were  excluded
rom  the  RV  volumes.  End-diastolic  and  end-systolic  volumes
ere  calculated  using  Simpson’s  rule  for  each  ventricle  and,
rom  these,  the  stroke  volume  and  EF  were  calculated.  RV
olumes  were  indexed  to  body  surface  area.  Two  orthogonal
ong-axis  views  of  the  RVOT  were  then  acquired  for  posi-
ioning  of  through-plane  ﬂow  quantiﬁcation  at  the  midpoint
f  the  pulmonary  trunk.  The  phase  contrast  CMR  sequence
as  performed  with  retrospective  ECG  gating,  breath  hold-
ng  and  the  following  variables:  repetition  time  7.3  ms,  echo
ime  2—3  ms,  two  views  per  segment  in  order  to  obtain  after
iew  sharing  a  temporal  resolution  of  15  ms  and  30—70  car-
iac  phases  depending  on  the  heart  rate;  256  ×  128  matrix
nterpolated  to  256  ×  256  in  raw  data  with  a  50%  rectan-
ular  ﬁeld  of  view  of  300—330  mm.  The  velocity  encoding
alue  (VENC)  was  set  initially  at  150  cm/s  and  adjusted  if
liasing  artefacts  occurred.  In  case  of  aliasing,  VENC  could
e
f
s
vler imaging measurements was 0.32; CMR RV ejection fraction was
e  increased  to  300  or  400  cm/s.  After  using  semiautomated
essel  edge  detection,  velocity  was  estimated  in  each  pixel
f  the  pulmonary  artery  section  to  measure  instantaneous
ow  in  mL/s,  further  integrated  throughout  the  cardiac
ycle,  to  calculate  anterograde  and  retrograde  volume  in
L.  The  PR  fraction  was  estimated  by  calculating  the  per-
entage  of  backward  ﬂow  volume  to  forward  ﬂow  volume.
tatistical analysis
n  our  study,  severe  PR  was  deﬁned  as  CMR  PR  fraction  ≥  50%.
V  dilatation  was  considered  important  when  CMR  EDRV  vol-
me  was  ≥  150  mL/m2,  according  to  the  results  of  surgical
VR  studies  [17,18].  According  to  the  normal  RVEF  values
easured  on  acquisitions  with  steady-state  free  precession
19],  RVEF  impairment  was  deﬁned  as  CMR  RVEF  <  50%.  The
ain  outcomes  were  the  presence  of  severe  PR,  impor-
ant  RV  dilatation  and  RVEF  impairment.  Patients  with  RVOT
epair  complications  were  deﬁned  as  patients  with  severe  PR
ssociated  with  important  RV  dilatation  and/or  RVEF  impair-
ent.
Univariate  analyses  (with  the  Wilcoxon  test,  Fisher’sxact  test,  the  Chi-square  test  or  the  Chi-squared  test
or  trends,  as  appropriate)  and  logistic  regression  analy-
es  were  used  to  identify  clinical  and  echocardiographic
ariables  associated  with  the  outcomes.  The  ﬁnal  models
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were  obtained  using  a  backward  selection,  where  predictive
factors  were  the  clinically  relevant  variables  and  echocar-
diographic  factors  that  had  a  P  value  <  0.20  in  the  univariate
test.  Clinically  relevant  variables  for  each  outcome  were
also  studied.  Linearity  on  the  scale  was  checked  for  quan-
titative  variables.  Multicolinearity  problems  were  assessed
using  correlation  matrices.
The  repeatability  (intraobserver  variability)  and  repro-
ducibility  (interobserver  variability)  of  the  echocardiogra-
phic  assessments  for  quantitative  variables  (EDRV  area,
ESRV  area,  RV  diameters,  Tei  index)  were  observed  on
Bland-Altman  plots  and  analysed  using  intraclass  correlation
coefﬁcients.  All  variables  (except  the  Tei  index)  were  log
transformed  to  satisfy  the  normal  distribution  assumption.
For  the  interobserver  study,  the  mean  of  the  two  measures
by  the  ﬁrst  observer  was  used.  The  assessment  of  the  PR
grade  was  analysed  with  kappa  coefﬁcients.
To  select  patients  requiring  close  CMR  monitoring,  we
used  a  scaled  score  to  estimate  the  risk  of  RVOT  repair
complication.  To  obtain  the  most  stable  model,  we  per-
formed  a  bootstrap  resampling  with  1000  replications
and  analysed  the  variables  and  combinations  of  variables
selected  from  the  1000  multivariable  logistic  regression
models  with  backward  selection.  The  choice  of  the  risk
factors  in  the  ﬁnal  model  was  based  on  the  frequency  of
selection  of  factors  and  combination  of  factors.  Once  this
step  was  achieved,  we  performed  another  1000  logistic
regressions  including  these  factors  in  order  to  estimate  the
regression  coefﬁcients  of  the  ﬁnal  model.  The  scores  asso-
ciated  with  quantitative  factors  were  determined  using  four
meaningful  categories  deﬁned  with  the  help  of  quartiles.
Finally,  we  presented  for  each  total  score  the  risk  of  RVOT
repair  complication  for  the  patient  and  the  sensitivity,  speci-
ﬁcity  and  likelihood  ratios  of  the  score  computed  on  the
original  sample.
SAS  statistical  software  (version  9.1;  SAS  Institute  Inc.,
Cary,  NC,  USA)  was  used  for  all  analyses.
Results
Study population
Patient  characteristics  are  listed  in  Table  1.  The  majority  of
patients  were  asymptomatic  (69.1%  New  York  Heart  Associ-
ation  class  I).  Seven  patients  (7%)  had  signs  of  right-sided
congestive  heart  failure.  All  patients  were  in  sinus  rhythm
during  their  examination.  Electrocardiography  showed  com-
plete  right  bundle  branch  block  in  82%  of  patients.  The
median  QRS  duration  was  150  ms.  Nineteen  patients  (20%)
had  QRS  ≥  180  ms;  26%  (24/94)  had  a  history  of  arrhythmia;
22/94  had  supraventricular  tachycardia;  and  2/94  had  non-
sustained  ventricular  tachycardia.
Correlates of severe RV dilatation, severe PR
and RVEF impairmentCriteria  for  severe  PR
We  identiﬁed  53  patients  (56%)  with  severe  PR  using  CMR.
The  univariate  analysis  showed  that  younger  age  at  RVOT
repair,  use  of  valvulotomy,  QRS  duration  and  echo-derived
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igh grade  of  PR  were  signiﬁcantly  associated  with  severe
R  in  CMR  (PR  ≥  50%).  The  other  echocardiographic  criteria
ere  not  correlated  with  PR  severity.  In  multivariable  anal-
sis,  valvulotomy  and  echo-derived  grade  of  PR  remained
igniﬁcant  (P  <  0.001)  correlates  of  severe  PR.  A  patient  with
n  echo-derived  PR  graded  3  was  almost  50  times  more  likely
o  have  severe  PR  in  CMR  (odds  ratio  [OR]  =  47.8,  95%  conﬁ-
ence  interval  [CI]  11.4—198.8;  P  <  0.001).  The  risk  of  severe
R  increased  about  ﬁve  times  for  a  patient  with  a  history  of
alvulotomy  (OR  5.4,  95%  CI  1.4—19.9;  P  =  0.012).
orrelates  of  RV  dilatation
hirty-ﬁve  out  of  94  (37%)  patients  had  important  RV  dilata-
ion  according  to  CMR  (Table  2).  The  univariate  analysis
howed  that  ToF,  presence  of  a  transannular  patch,  QRS
uration,  indexed  RV  diameters  and  indexed  EDRV  and  ESRV
reas  were  signiﬁcantly  associated  with  RV  dilatation  in
MR  (EDRV  volume  ≥  150  mL/m2).  After  backward  selection
n  multivariable  logistic  regression,  QRS  duration,  indexed
DRV  diameter  and  indexed  EDRV  area  in  echocardiogra-
hy  remained  signiﬁcantly  associated  with  RV  dilatation  in
MR  (P  <  0.001).  Patients  with  the  largest  QRS,  indexed  EDRV
iameter  and/or  indexed  EDRV  area  were  more  likely  to
ave  RV  dilatation.  For  an  increase  of  5  mm/m2 in  indexed
DRV  diameter,  the  risk  of  important  RV  dilatation  increased
ore  than  two  times  (OR  2.2,  95%  CI  1.2—3.9;  P  =  0.007).
he  OR  for  an  increase  of  5  cm2/m2 in  indexed  EDRV  area
as  1.6  (95%  CI  1.1—2.4;  P  =  0.010)  and  an  increase  of  10  ms
n  QRS  resulted  in  a  1.3  times  increase  in  the  risk  of  having
mportant  RV  dilatation  (OR  1.3,  95%  CI  1.03—1.6;  P  =  0.021).
riteria  for  RVEF  impairment
n  CMR,  we  identiﬁed  53  patients  (64%)  with  RVEF  impair-
ent  (RVEF  <  50%)  (Table  3).  Univariate  analysis  showed
hat  ToF,  presence  of  a  transannular  patch,  QRS  duration,
rrhythmia,  Tei  index  and  RV  shortening  fraction  area  were
igniﬁcantly  associated  with  RVEF  impairment.  In  multi-
ariable  logistic  regression  analysis,  only  arrhythmia  and
ei  index  remained  signiﬁcant  correlates  of  RVEF  impair-
ent  (P  =  0.045  and  P  <  0.001,  respectively).  An  increase  of
.05  units  in  the  Tei  index  resulted  in  a  two  times  increase
n  the  risk  of  having  RVEF  impairment  (OR  2.0,  95%  CI
.4—2.6;  P  <  0.001).  RVEF  impairment  was  six  times  more
ikely  to  occur  among  patients  with  arrhythmia  (OR  6.2,  95%
I  1.3—27.8;  P  =  0.017).
epeatability and reproducibility of
chocardiographic measurements
hese  data  can  be  found  in  the  online  Data  Supplement
Fig.  2).
trategy for  selecting patients who need close
MR follow-up
ccording  to  our  deﬁnition,  44  patients  (47%)  had  RVOT
epair  complications  diagnosed  by  CMR  (Tables  4  and  5).
ourteen  patients  had  the  three  complications  of  the
omposite  criterion  and  13  patients  had  no  complication.
he  univariate  analysis  showed  that  the  presence  of  a
ransannular  patch,  valvulotomy,  QRS  duration,  arrhythmia,
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Table  2  Correlates  of  right  ventricular  dilatation.
Characteristics  Important  RV  dilatationa P†
Yes  (n  =  35)  No  (n  =  59)
Demographic  and  clinical
Men  21  (60.0)  25  (42.4)  <  0.1
Tetralogy  of  Fallot  29  (82.9)  36  (61.0)  <  0.05
Age  of  RVOT  repair  (months)  36  (1.6;240)  24  (1;684)  NS
Time  since  surgery  (years)  26  (11;41)  23  (3;48)  NS
Transannular  patch  31  (88.6)  35  (59.6)  <  0.01
Valvulotomy  7  (20.0)  20  (33.9)  NS
Arrhythmia  history  11  (31.4)  11  (18.6)  NS
NYHA  >  1 13 (37.1)  16 (27.1)  NS
Right  congestive  heart  failure  5  (14.3)  2  (3.4)  <  0.1
Electrocardiographic
QRS  duration  (ms)  160  (150—180)  130  (100—160)  <  0.01
Echocardiographic
Indexed  EDRV  diameter  (mm/m2)  23 (19—28)  19  (15—22)  <  0.01
Indexed  ESRV  diameter  (mm/m2)  17 (15—23)  16  (14—22)  NS
Indexed  EDRV  area  (cm2/m2) 23 (19—24) 17 (14—19)  <  0.01
Indexed  ESRV  area  (cm2/m2) 12 (8—15) 8 (6—10) <  0.01
Tricuspid  regurgitation  grade  ≥  2 13 (37.1)  16 (27.1)  NS
Data are number (%), median (minimum;maximum) or median (interquartile range). EDRV: end-diastolic right ventricular; ESRV: end-
systolic right ventricular; NS: not signiﬁcant; NYHA: New York Heart Association; RV: right ventricular; RVOT: right ventricular outﬂow
tract.
a Important RV dilatation deﬁned by indexed EDRV volume ≥ 150 mL/m2.
† P value was determined with the Wilcoxon test, Fisher’s exact test, the chi-squared test or the Chi-squared test for trends, as
appropriate.
Table  3 Correlates  of  right  ventricular  ejection  fraction  impairment.
Characteristics  RVEF  impairmenta P†
Yes  (n  =  60)  No  (n  =  34)
Demographic  and  clinical
Men  30  (50.0)  16  (47.0)  NS
Tetralogy  of  Fallot  46  (76.7)  19  (55.9)  <  0.05
Age  of  RVOT  repair  (months)  33  (1;684)  24  (1.2;684)  NS
Time  since  surgery  (years)  23  (3;41)  23  (6;48)  NS
Transannular  patch  50  (83.3)  16  (47.1)  <  0.01
Valvulotomy  15  (25.0)  12  (35.3)  NS
Arrhythmia  history  18  (30.0)  4  (11.8)  <  0.05
NYHA  >  1  19  (31.7)  10  (29.4)  NS
Right  congestive  heart  failure  5  (8.3)  2  (5.9)  NS
Electrocardiographic
QRS  duration  (ms)  150  (120—180)  135  (100—150)  <  0.05
Echocardiographic
Tei  index 0.37 (0.21—0.47) 0.11 (0.08—0.18)  <  0.01
Shortening  fraction  area  (%)  46  (40—56)  55  (45—63)  <  0.01
Peak  S  wave  10  (8—11)  10  (7—12)  NS
IVA  1.4  (0.7—1.9)  0.9  (0.6—1.6)  NS
Data are number (%), median (minimum;maximum) or median (interquartile range). IVA: isovolumic acceleration; NS: not signiﬁcant;
NYHA: New York Heart Association; REFV: right ventricular ejection fraction; RVOT: right ventricular outﬂow tract.
a RVEF impairment deﬁned by RVEF < 50%.
† P value was determined with the Wilcoxon test, Fisher’s exact test, the chi-squared test or the Chi-squared test for trends, as
appropriate.
CMR  follow-up  of  chronic  pulmonary  regurgitation  
Table  4  Scoring  system  to  evaluate  the  risk  of  right
ventricular  outﬂow  tract  repair  complications:  points
associated  with  each  risk  factor  category.
Risk  factor Categories  Points
QRS  duration <  110  0
110—139  2
140—169  4
≥  170 6
Arrhythmia No 0
Yes 3
Valvulotomy No 0
Yes  5
Echocardiographic  grade  of  PR  ≤  2  0
3  8
PR: pulmonary regurgitation.
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(echocardiographic  grade  of  severe  PR,  Tei  index,  indexed
EDRV  diameter  and  indexed  EDRV  and  ESRV  areas  were
signiﬁcantly  associated  with  a  high  risk  of  RVOT  repair
complications.  The  backward  selection  of  the  multivariable
f
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Table  5  Scoring  system  to  evaluate  the  risk  of  right  ventricu
score  and  diagnostic  indices.
Total  scorea Estimate  of  risk† Sensitivit
0  0.058  100.0  
1
2  0.12  100.0  
3  0.169  100.0  
4  0.233  100.0  
5  0.311  100.0  
6  0.402  100.0  
7  0.501  100.0  
8  0.599  97.7  
9  0.69  97.7  
10  0.768  97.7  
11  0.832  97.7  
12  0.88  90.9  
13  0.916  86.3  
14  0.942  77.2  
15 0.96  70.4  
16 0.973  52.3  
17 0.982  50.0  
18 0.988  22.7  
19  0.992  13.6  
20  0.994  13.6  
21  0.996  6.8  
22  0.997  6.8  
LR: likelihood ratio.
a Theoretical total score achieved by adding the points associated wit
possible.
† Derived from a logistic model equation. Computed on the original s
predicting the risk of right ventricular outﬂow tract (RVOT) repair com
the total score for the patient was greater than or equal to the theore33
ogistic  regression  models  revealed  that  grade  of  PR,  valvu-
otomy,  arrhythmia  and  duration  of  QRS  were  respectively
elected  in  77%,  63%,  64%  and  47%  of  the  bootstrap  replica-
ions  (other  factors  were  selected  in  fewer  than  one  third  of
he  replications).  Grade  of  PR  and  valvulotomy  correlated
ighly  with  the  presence  of  RVOT  repair  complications,  as
he  combination  of  the  two  factors  was  present  in  48%  of  the
odel.  To  estimate  the  risk  of  RVOT  repair  complications,
e  thus  included  the  grade  of  PR,  valvulotomy,  arrhythmia
nd  duration  of  QRS  in  the  scaled  scoring  system.  Table  4
hows  the  scores  associated  with  each  risk  factor  category.
R  grades  1  and  2  were  grouped  to  avoid  a  problem  of  esti-
ation  in  the  logistic  model  due  to  zero  cases  and  QRS
uration  was  split  into  four  categories  of  30  ms  intervals.
able  5  shows  the  theoretical  total  score  and  the  diagnostic
ndices  of  the  system  for  predicting  the  presence  of  RVOT
epair  complications  diagnosed  by  CMR  (computed  on  the
riginal  sample  using  the  theoretical  score  as  the  cutoff
alue).  The  theoretical  total  score  ranged  from  0  to  22.
ll  44  patients  with  RVOT  repair  complications  identiﬁed  by
MR  had  a  points  total  ≥  7,  ensuring  a  sensitivity  of  100%
no  false  negative)  if  the  cutoff  value  of  7  points  was  chosen
or  predicting  CMR  on  the  original  sample.  Using  a  cutoff
alue  of  11  points  led  to  a  sensitivity  of  97.7%  to  detect
omplicated  patients  (one  CMR  examination  not  having  been
lar  outﬂow  tract  repair  complications:  theoretical  total
y  Speciﬁcity  LR+  LR−
0.0  1.00
10.0  1.11  0.0
18.0  1.22  0.0
26.0  1.35  0.0
30.0  1.43  0.0
38.0  1.61  0.0
38.0  1.61  0.0
44.0  1.75  0.05
50.0  1.95  0.05
58.0  2.33  0.04
58.0  2.33  0.04
66.0  2.67  0.14
80.0  4.32  0.17
84.0  4.83  0.27
84.0  4.40  0.35
92.0  6.53  0.52
92.0  6.25  0.54
100.0  6.25  0.77
100.0  6.25  0.86
100.0  6.25  0.86
100.0  6.25  0.93
100.0  6.25  0.93
h the risk factor categories (Table 4); a total score of 1 was not
ample using each theoretical total score as the cutoff value for
plication. RVOT repair complication was predicted as ‘present’ if
tical total score in the table.
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ecommended  when  it  should  have  been)  or  unnecessary
lose  CMR  follow-up  (29/94  patients,  31%).
iscussion
linical,  ECG  and  echocardiographic  criteria  can  be  used  to
dentify  patients  with  and  without  complications  of  RVOT
econstruction  (i.e.  signiﬁcant  PR  and  important  RV  dilata-
ion  or  RV  dysfunction  deﬁned  by  CMR).  By  combining
ariables  readily  available  in  a  simple  score,  we  were  able
o  differentiate  patients  at  high  risk  of  complications  who
equire  close  CMR  monitoring  from  low-risk  patients  who
ould  reasonably  have  less  frequent  CMR  follow-up.
The  criteria  we  chose  to  select  RVOT  repair  complications
n  our  study  have  been  previously  evaluated  individually  in
everal  studies.  As  a  ﬁrst  step,  we  compared  these  pre-
iously  described  criteria  to  better  differentiate  patients
ithout  any  long-term  RVOT  repair  complications  from  oth-
rs.  The  most  powerful  criterion  of  severe  PR  was  the  extent
f  the  diastolic  retrograde  PR  ﬂow  by  pulsed  Doppler  within
he  pulmonary  artery  tree.  This  result  was  also  found  by
enella  et  al.  [12]. In  the  present  study,  PHT  was  found  to
e  less  predictive  of  severe  PR  than  location  of  pulmonary
iastolic  retrograde  ﬂow,  and  we  did  not  ﬁnd  any  relation-
hip  between  PR  index  and  PR  fraction.  These  two  indices
epend  strongly  on  RV  diastolic  function,  which  could  be
ery  different  between  patients.  As  previously  shown,  QRS
uration  was  also  found  to  be  signiﬁcantly  associated  with  RV
ilatation  [20]. But  further  criteria  were  also  well  correlated
o  the  CMR  RV  volume,  such  as  the  echocardiographic  crite-
ia  of  EDRV  area  and  EDRV  diameter.  According  to  present
chocardiography  guidelines,  assessment  of  RV  size  is  best
erformed  in  the  apical  four-chamber  view,  with  reference
imits  provided  for  both  RV  diastolic  and  systolic  areas  and
or  RV  area  fraction  [21]. Indexed  RV  areas  were  also  used
y  Greutman  et  al.  [7].  Good  correlation  of  echocardiog-
aphic  RV  area  to  RV  volume  was  also  found  in  our  study
nd  very  good  reproducibility  of  echocardiography  mea-
urements  was  obtained,  making  this  method  suitable  for
stimating  RV  volume  in  routine  practice.  As  in  the  study
y  Yasuoka  et  al.  [9],  the  TDI-derived  Tei  index  appears  to
e  a  simple  and  reliable  method  for  the  evaluation  of  RV
ystolic  function  in  repaired  ToF.  Other  echocardiographic
ndices  based  on  RV  longitudinal  contraction,  such  as  tri-
uspid  annular  plane  systolic  excursion,  longitudinal  strain
nd  strain  rate,  failed  to  assess  CMR  RVEF  [22]. Addition-
lly,  arrhythmia  is  closely  related  to  RV  systolic  dysfunction.
ate  arrhythmia  may  be  a  surrogate  marker  for  RV  dysfunc-
ion  and  these  patients  may  also  be  at  risk  of  ventricular
achycardia.
As  a  second  step,  because  the  combination  of  PR  grade
nd  valvulotomy  correlated  highly  with  the  presence  of
VOT  repair  complications  and  was  present  in  48%  of  the
ultivariable  logistic  regression  models,  we  included  these
ariables  in  the  scaled  scoring  system.  Thus,  by  using
he  grade  of  PR  and  history  of  valvulotomy  in  associa-
ion  with  arrhythmia  and  duration  of  QRS,  we  found  that readily  available  practical  score  can  be  used  to  detect
omplications  after  RVOT  reconstruction.  As  illustrated  in
able  5,  when  the  score  is  ≥  11,  the  sensitivity  to  detect
omplications  using  CMR  is  greater  than  97%.  Twenty-nineM.  Ladouceur  et  al.
f  94  subjects  (31%)  had  a  score  <  11,  meaning  that  the
hance  of  complications  is  very  low  in  these  selected  sub-
ects  and  that  CMR  should  be  less  useful  and  could  be
sed  less  frequently  in  the  follow-up.  Conversely,  with  a
core  ≥  11,  CMR  should  be  included  in  the  clinical  visit  and
lose  CMR  monitoring  is  recommended  in  the  follow-up.  The
maging  follow-up  strategy  concerning  the  use  of  CMR  is
till  unclear  and  will  require  longitudinal  studies  to  bet-
er  deﬁne  outcome  after  RVOT  reconstruction.  CMR  is  a
ime-consuming  technique  due  to  long  data-acquisition  and
nalysis  time,  and  a  follow-up  strategy  with  systematic  and
requent  repetition  of  CMR  will  be  very  expensive  after  RVOT
econstruction  if  applied  to  all  patients  indiscriminately.
tudy limitations
e  evaluated  the  performance  of  a  total  points  score  on
he  original  sample  but  this  method  needs  to  be  further
valuated  in  a  prospective  study.  In  order  to  produce  sim-
le  decision  rules  for  clinical  use,  we  limited  the  number
f  factors  in  the  scoring  system.  However,  some  factors  not
etained  in  the  ﬁnal  scoring  system  had  a  sizeable  inﬂuence
n  RVOT  repair  complications;  these  included  transannular
atch,  Tei  index  and  indexed  RV  anterior-posterior  diame-
ers  and  areas.  These  factors  must  be  further  explored.
onclusion
 combination  of  clinical,  ECG  and  readily  available  echocar-
iographic  criteria  can  be  helpful  in  the  follow-up  of  patients
fter  RVOT  repair  and  chronic  PR.  Arrhythmia  history,  QRS
uration,  Doppler  PR  degree,  EDRV  area  and  Tei  index  iden-
ify  patients  with  severe  PR  associated  with  important  RV
ilatation  and/or  RV  dysfunction.  A  simple  scoring  sys-
em  based  on  these  criteria  allows  better  identiﬁcation
f  patients  with  signiﬁcant  RVOT  repair  complications  who
eed  close  CMR  follow-up,  and  those  without  complications
ho  do  not  need  short-term  CMR  evaluation.  This  approach
llows  the  follow-up  strategy  to  be  tailored  to  each  patient
nd  optimization  of  the  use  of  CMR  in  this  setting.
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